⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14407779 | 1.00 | CYP1A2 (0.77) | — | |
| SCHEMBL860793 | 1.00 | CYP1A2 (0.77) | — | |
| SCHEMBL1197207 | 0.90 | CYP1A2 (0.65) | — | |
| SCHEMBL10401946 | 0.87 | CYP1A2 (0.62) | — | |
| SCHEMBL9183693 | 0.87 | CYP1A2 (0.62) | — | |
| SCHEMBL13925516 | 0.87 | CYP1A2 (1.00) | — | |
| SCHEMBL33260 | 0.87 | CYP1A2 (1.00) | — | |
| SCHEMBL2991648 | 0.87 | CYP1A2 (0.62) | — | |
| SCHEMBL18559949 | 0.87 | CYP1A2 (0.62) | — | |
| SCHEMBL220868 | 0.87 | CYP1A2 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1616 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250082747-A1 | PORCINE CORONAVIRUS VACCINES | Boehringer Ingelheim Animal Health USA Inc. | 2025-03-13 | — | — | US | claimed |
| US-20230212230-A1 | INFLUENZA VIRUS PRODUCTION METHOD USING SINGLE-USE CULTURE PROCESS SYSTEM AND RAPID CONFIRMATION TEST OF INFLUENZA VIRUS ANTIGEN PURIFICATION CONDITION | SK BIOSCIENCE CO., LTD. (KP) | 2023-07-06 | — | — | US | claimed |
| EP-4144753-A1 | INFLUENZA VIRUS PRODUCTION METHOD USING DISPOSABLE CULTURE PROCESS SYSTEM, AND TEST FOR QUICKLY CHECKING CONDITIONS FOR INFLUENZA VIRUS ANTIGEN PURIFICATION | SK Bioscience Co., Ltd. (KR) | 2023-03-08 | — | — | EP | claimed |
| US-11529407-B2 | Isolation of a novel pestivirus causing congenital tremor A | VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2022-12-20 | — | — | US | claimed |
| US-11478541-B2 | Method for inactivating Zika virus and for determining the completeness of inactivation | TAKEDA VACCINES, INC. (US) | 2022-10-25 | — | — | US | claimed |
| US-20220211836-A1 | INACTIVATED VIRUS COMPOSITIONS AND ZIKA VACCINE FORMULATIONS | TAKEDA VACCINES, INC. (US) | 2022-07-07 | — | — | US | claimed |
| CN-108135993-B | Pestivirus vaccine for congenital tremor | 贝林格尔·英格海姆维特梅迪卡有限公司 | 2022-03-22 | — | — | CN | claimed |
| EP-3965811-A1 | INACTIVATED VIRUS COMPOSITIONS AND ZIKA VACCINE FORMULATIONS | Takeda Vaccines, Inc. (US) | 2022-03-16 | — | — | EP | claimed |
| CN-113939311-A | Inactivated virus composition and Zika vaccine preparation | 武田疫苗股份有限公司 | 2022-01-14 | — | — | CN | claimed |
| US-20220008543-A1 | MACROMOLECULAR PRODRUG-BASED THERMOSENSITIVE INJECTABLE GEL AS A NOVEL DRUG DELIVERY PLATFORM | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-01-13 | — | — | US | claimed |
| US-5698432-A | PRODUCING INACTIVATED WHOLE VIRUS BY TREATING WITH GENERAL INACTIVATING AGENT, DEAGGREGATING AGENT, NUCLEIC ACID INACTIVATING AGENT, THEN STABILIZING WITH CROSSLINKING AGENT | RETROSCREEN LTD. (GB) | 1997-12-16 | — | — | US | claimed |
| US-5498409-A | TO REMOVE ENDOTOXINS IN MEDICAL SOLUTIONS SUCH AS INJECTIONS, TRANFUSIONS OR SALINE, A POLYETHYLENIMINE MIXED WITH ANOTHER POLYMER | Hirayama, Chuichi (JP) | 1996-03-12 | — | — | US | claimed |
| US-5401499-A | With polymine from an aziridine compound | SHINKOHJINKASEI CO., LTD. (JP) | 1995-03-28 | — | — | US | claimed |
| EP-0409783-B1 | Polymer base blend compositions containing destructurized starch | WARNER LAMBERT CO (US) | 1994-06-15 | — | — | EP | claimed |
| EP-0514199-A2 | Vaccines and methods for their production | RETROSCREEN LIMITED (GB) | 1992-11-19 | — | — | EP | claimed |
| US-5095054-A | Molding premixes of a melt of a degraded starch and hydrophobic water-insoluble thermoplastic polymer; dimensional stability; toughness; humidity resistance; receptivity | WARNER-LAMBERT COMPANY (US) | 1992-03-10 | — | — | US | claimed |
| EP-0409783-A2 | Polymer base blend compositions containing destructurized starch | WARNER-LAMBERT COMPANY (US) | 1991-01-23 | — | — | EP | claimed |
| EP-0145783-B1 | CANINE CORONAVIRUS VACCINE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1990-03-14 | — | — | EP | claimed |
| US-4567042-A | VETERINARY MEDICINE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1986-01-28 | — | — | US | claimed |
| US-4540747-A | POLYOXAZOLINES AND OXAZINES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-09-10 | — | — | US | claimed |